Skip to main content
. 2021 Sep 28;215(9):420–426. doi: 10.5694/mja2.51278

Time point

Characteristic

T0

T1

T2

T3

Number of patients

4371

3886

3453

2923

Sex

Male

2051 (46.9%)

1885 (48.5%)

1636 (47.4%)

1392 (47.6%)

Female

2317 (53.0%)

2000 (51.5%)

1805 (52.3%)

1518 (51.9%)

Other/missing data

3

1

12

13

Age (years)

0–14

1184 (27.1%)

999 (25.7%)

876 (25.4%)

792 (27.1%)

15–24

645 (14.8%)

562 (14.5%)

575 (16.7%)

475 (16.3%)

25–34

813 (18.6%)

723 (18.6%)

670 (19.4%)

556 (19.0%)

35–44

668 (15.3%)

608 (15.6%)

519 (15.0%)

414 (14.2%)

45–54

508 (11.6%)

439 (11.3%)

371 (10.7%)

320 (10.9%)

55–64

312 (7.1%)

297 (7.6%)

263 (7.6%)

210 (7.2%)

65 or more

241 (5.5%)

258 (6.6%)

179 (5.2%)

156 (5.3%)

Intervention group

Early intervention

1108 (25.3%)

1152 (29.6%)

1049 (30.4%)

0

Late intervention

3263 (74.7%)

2734 (70.4%)

2404 (69.6%)

2923 (100%)

Intervention status

Not yet received

4371 (100%)

2734 (70.4%)

0

0

Received

0

1152 (29.6%)

3453 (100%)

2923 (100%)

Area

1

1447 (33.1%)

1042 (26.8%)

957 (27.7%)

494 (16.9%)

2

737 (16.9%)

682 (17.6%)

509 (14.7%)

349 (11.9%)

3

2187 (50.0%)

2162 (55.6%)

1987 (57.5%)

2080 (71.2%)

Country of birth/ethnic background*

Iraq/Iraqi

1862 (42.6%)

1634 (42.0%)

1439 (41.7%)

1582 (54.1%)

Syria/Syrian

694 (15.9%)

738 (19.0%)

513 (14.9%)

329 (11.3%)

Afghanistan/Afghani

323 (7.4%)

284 (7.3%)

302 (8.7%)

164 (5.6%)

Other

836 (19.1%)

722 (18.6%)

783 (22.7%)

569 (19.5%)

Missing

656 (15.0%)

508 (13.1%)

416 (12.0%)

279 (9.5%)

*

Field name according to recording software used by the practice.